HBeAg Negativity Is Associated With More Advanced Liver Fibrosis in Patients With Chronic Hepatitis B-Reference-Cited by-同舟云学术

HBeAg Negativity Is Associated With More Advanced Liver Fibrosis in Patients With Chronic Hepatitis B

Published:2019-11-27 Issue:9 Volume:54 Page:826-831
ISSN:0192-0790
Container-title:Journal of Clinical Gastroenterology
language:en
Short-container-title:

Author:

Wang Jian,Wu Weihua,Yan Xiaomin,Wei Jie,Yao Kefang,Yang Yue,Xiong Yali,Xia Juan,Liu Yong,Chen Yuxin,Jia Bei,Zhang Zhaoping,Ding Weimao,Huang Rui,Wu Chao

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Reference16 articles.

1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

2. AASLD guidelines for treatment of chronic hepatitis B;Terrault;Hepatology,2016

3. EASL clinical practice guidelines: management of chronic hepatitis B virus infection;J Hepatol,2012

4. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection;J Hepatol,2017

5. Influence of age and HBeAg status on the correlation between HBV DNA and hepatic inflammation and fibrosis in chronic hepatitis B patients;Bai;Dig Dis Sci,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiobioinformatics: A novel bridge between basic research and clinical practice for clinical decision support in diffuse liver diseases;iRADIOLOGY;2023-06

2. Liver fibrosis is closely related to metabolic factors in metabolic associated fatty liver disease with hepatitis B virus infection;Scientific Reports;2023-01-25

3. Values of Serum HBsAg and HBeAg Levels for Virological Response of Patients with HBV-Related Liver Cirrhosis Treated by Entecavir;Clinical Laboratory;2023

4. MAFLD is Associated with the Risk of Liver Fibrosis and Inflammatory Activity in HBeAg-Negative CHB Patients;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-03